Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CC-10004 for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 12 adverse event reports in the FDA FAERS database where CC-10004 was used for Psoriasis.

Other Indications for CC-10004

Psoriatic arthropathy (5)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

CC-10004 Full Profile All Psoriasis Drugs CC-10004 Demographics CC-10004 Timeline